A Study of ARC-02 in B-cell NHL

Clinical trial NCT07691606 · RECRUITING

Trial details

NCT number: NCT07691606
Sponsor: Taiho Oncology, Inc.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

B-cell Non Hodgkin Lymphoma

Start date: 2026-06-22
Primary completion: 2029-01-01
Enrollment: 140

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.